www.freseniusmedicalcare.com Open in urlscan Pro
52.222.214.113  Public Scan

Form analysis
1 forms found in the DOM

/en/search

<form action="/en/search">
  <div class="floating-input"><span class="absolute inset-y-0 right-3.5 flex items-center"><button class="flex items-center p-1 focus:outline-none focus:shadow-outline text-brandBlue-500" title="Search" type="submit"><span
          class="icon-search text-2xl"></span></button></span><input class="form-input form-search w-full lg:bg-effectiveBlue-100 lg:bg-opacity-20 lg:border-opacity-100" id="header-search" name="q" type="search"><label for="header-search"
      class="inputEmpty"> Search </label></div>
</form>

Text Content

Skip to content
Search
Language EN
 * EN
 * DE

Menu Close
 * Patients & Families
 * Healthcare Professionals
 * Investors
 * Media
 * Sustainability
 * About us

 * Homepage
 * Patients & Families
   * Back
   *  
   * Patients & Families
   * Patients & Families overview
   * I have kidney disease
     * Back
     *  
     * I have kidney disease
     * I have kidney disease
     * How do my kidneys work
     * Preventing further kidney damage
     * Why kidney replacement therapy?
     * My support team
     * A physicians appointment
   * My therapy options
     * Back
     *  
     * My therapy options
     * My therapy options
     * Making the right decision
     * Kidney replacement therapy decision aid tool for patients
     * Answers to further questions
   * My preparations for dialysis
     * Back
     *  
     * My preparations for dialysis
     * My preparation for dialysis
     * Preventing complications
     * Important questions about preparation
   * My life with dialysis
     * Back
     *  
     * My life with dialysis
     * My life with dialysis
     * Enjoying life with dialysis
   * Life as a family member
     * Back
     *  
     * Life as a family member
     * Life as a family member
     * Support possibilities
   * Dialysis center finder
 * Healthcare Professionals
   * Back
   *  
   * Healthcare Professionals
   * Healthcare Professionals overview
   * Hemodialysis
     * Back
     *  
     * Hemodialysis
     * Hemodialysis overview
     * HighVolumeHDF
       * Back
       * HighVolumeHDF
       * Why HighVolumeHDF?
     * Machines
       * Back
       * Machines
       * Machines overview
       * 6008 CAREsystem
       * 5008S CorDiax
       * 4008 series hemodialysis machines
     * Dialyzers
       * Back
       * Dialyzers
       * Dialyzers overview
       * FX CorDiax dialyzers
       * FX classix dialyzers
       * FX high and low-flux dialyzers
     * Water technology
       * Back
       * Water technology
       * Water technology overview
       * Water technology solutions
       * Dialysis water supply
       * Concentrate supply
       * Media supply
     * Individualized sodium management
     * Access Flow Monitor
     * Advanced Fluid Management
       * Back
       * Advanced Fluid Management
       * Advanced Fluid Management overview
       * BCM - Body Composition Monitor
     * HD fluid management
   * Home therapies
     * Back
     *  
     * Home therapies
     * Home therapies overview, transition & CKD
     * Peritoneal dialysis
       * Back
       * Peritoneal dialysis
       * Peritoneal dialysis overview
       * Virtual reality training for PD
       * Fluids for PD
       * CAPD
       * APD
       * PD support and monitoring
     * Home hemodialysis
       * Back
       * Home hemodialysis
       * Home hemodialysis overview
       * NxStage VersiHD
       * NxStage System One
       * 5008S CorDiax
     * Environment
       * Back
       * Environment
       * Environment
   * Critical care - Multi-organ support
     * Back
     *  
     * Critical care - Multi-organ support
     * Critical care
     * Acute blood purification
       * Back
       * Acute blood purification
       * Acute blood purification
       * Therapeutic applications
       * Ci-Ca therapy
       * multiFiltratePRO
       * Ready4 multiFiltratePRO AR
       * Disposables and fluids
     * Heart and lung support
       * Back
       * Heart and lung support
       * Heart and lung support
     * Therapeutic apheresis
       * Back
       * Therapeutic apheresis
       * Therapeutic apheresis
       * Therapeutic applications
       * Immunoadsorption
       * Lipoprotein apheresis
       * Apheresis platforms
   * Pediatric dialysis
     * Back
     *  
     * Pediatric dialysis
     * Pediatric dialysis overview
     * Pediatric peritoneal dialysis
     * Pediatric hemodialysis
   * Patient seating & weighing
     * Back
     *  
     * Patient seating & weighing
     * Patient seating & weighing overview
     * Therapy chairs
     * Therapy beds
     * Medical scales
   * Renal IT
     * Back
     *  
     * Renal IT
     * Renal IT overview
     * Therapy Data Management System (TDMS)
     * Therapy Monitor (TMon)
     * Therapy Support Suite (TSS)
     * communication Data Link (cDL)
     * Nephrologic Cockpit
     * PatientOnLine (POL)
     * Clinical management
     * Service and support
     * Physicians
     * Nurses
   * Services and resources
     * Back
     *  
     * Services and resources
     * Services and resources overview
     * Educational videos and resources
       * Back
       * Educational videos and resources
       * Dialysis training videos and materials
     * Training and education
     * Events and congresses
     * Educational grants
     * Research grants
     * Medical information
 * Investors
   * Back
   *  
   * Investors
   * Investors overview
   * Equity story
     * Back
     *  
     * Equity story
     * Equity story overview
     * Strategy
     * Sustainability
     * Financials
   * Shares
     * Back
     *  
     * Shares
     * Share price
     * Share data
     * Dividend
     * Share buy-back
     * ADR program
     * NxStage
     * Shareholder structure
     * Notification of voting rights
     * Analysts and consensus estimates
   * News
   * Ad hoc notifications
   * Publications
     * Back
     *  
     * Publications
     * Publications
     * Facts & Figures
   * Events
     * Back
     *  
     * Events
     * Events overview
     * Financial calendar
     * Conferences & roadshows
     * Capital Markets Day
     * Meet the Management
   * Annual General Meeting
   * Creditor Relations
   * Corporate Governance
     * Back
     *  
     * Corporate Governance
     * Corporate Governance overview
     * Legal structure
     * Supervisory Board
     * Remuneration of the Supervisory Board
     * Compensation of the Management Board
     * Declaration on Corporate Governance
     * Declaration of Compliance
     * Managers' transactions
   * Investor Relations contacts
 * Media
   * Back
   *  
   * Media
   * Media overview
   * Newsroom
   * Insights
     * Back
     *  
     * Insights
     * Patient Stories
     * Company Features
   * Multimedia
     * Back
     *  
     * Multimedia
     * Images
     * Videos
     * Publications
   * Events
   * Media Relations contacts
 * Sustainability
   * Back
   *  
   * Sustainability
   * Sustainability overview
   * Our commitment
   * Patients
   * Medical responsibility
   * Employees
   * Environment
   * Supply chain
   * Society
   * Policies and standards
   * Indices and ESG ratings
 * About us
   * Back
   *  
   * About us
   * About us overview
   * Company profile
   * Corporate culture
   * Ventures
   * Strategy
   * Compliance
     * Back
     *  
     * Compliance
     * Compliance Overview
     * Our Code of Ethics and Business Conduct
     * You speak up – we listen!
     * Information for our Business Partners
     * Policies and standards
   * Management Board
   * Supervisory Board
   * History
   * Glossary
 * Contact
 * Career

Select language ENDE
Country websites Global websiteAustraliaAustriaBrazilChileChinaColombiaCzech
RepublicDenmarkEcuadorFinlandFranceGermanyHong
KongHungaryIndiaIndonesiaItalyJapanKazakhstanKoreaMalaysiaMexicoMiddle
EastMoroccoPakistanPhilippinesPeruPolandPortugalRomaniaRussiaSingaporeSouth
KoreaSpainSwedenSwitzerlandTaiwanThaiTürkiyeUkraineUnited KingdomUnited
StatesVietnam
HomeHealthcare ProfessionalsHome therapiesPeritoneal dialysisAPD


APD


AUTOMATED PERITONEAL DIALYSIS WITH SLEEP•SAFE HARMONY AND SILENCIA




DISCLAIMER

Not all products and services are cleared or available for sale in all EU
countries. Check your country web site for details. 


WHY AUTOMATED PERITONEAL DIALYSIS (APD)?

APD uses a programmable machine, or cycler, that controls the volume, filling,
dwell time and drainage of the solution. Thanks to automated dialysis, patients
can be dialyzed at home, even when sleeping.

As APD is offering more free daytime, it is the PD technique with obvious
advantages for patient’s lifestyle. Patients may pursue a job and have more time
for personal and family activities.1

Finally, APD cyclers offer a variety of individualization options for the
treatment, allowing you to even better consider the needs of your patient,
supporting you to improve patient care.


IN APD BOTH OUR CYCLERS, SLEEP•SAFE HARMONY AND SILENCIA, OFFER ADVANCED
FEATURES, ALL AIMED AT IMPROVING PATIENT CARE.

 * Increased treatment flexibility with FlexPoint technology3
 * Integrated on-screen animations give guidance and facilitate setup3
 * As proposed by Fischbach et al., potentially improved ultrafiltration and
   clearance with individually adapted APD (aAPD)2


GETTING STARTED WITH EDUCATION IN APD – THE DIFFICULT PART WAS MAKING IT EASIER

FMC created training solutions that focus on conveying the information that
really matter and offers support in preparing and setting up the treatment.

2

PREPARATION

TRAIN

 * Spot-on training videos for caregivers and patients to support training
 * Start with supportive extra training material for our APD devices
 * Set of patient information materials to support you in training the patient

START

 * Support in planning and preparing the therapeutic home environment

left
right


OUR PRODUCTS - KEY FEATURES OF THE SLEEP·SAFE HARMONY

sleep·safe harmony offers features aimed at improving patient care. It also
provides training support by guiding on-screen animations directly on the
device.


Guided prescriptions
 * Create prescriptions directly on the device
 * On-screen keyboard
 * Improved fluid usage – no extra volume for priming

FlexPoint intelligence combines settings such as:
 * Permitted patient volume – the maximum individual fill volume
 * Permitted residual volume – the maximum individual volume that may remain in
   the patient’s peritoneal cavity
    
 * The goal is to:
   * Reduce potential outflow alarms for a more quiet and restful sleep
   * Maintain the prescribed treatment time
   * Improve treatment effectiveness
   * Provide more flexibility in treatment execution within defined individual
     limits to improve patients’ well-being and safety

Convenient handling
 * Automatic connection and barcode recognition of bags
 * Integrated handles
 * PatientCardplus capable of storing up to nine different prescriptions and
   more than 12 months of treatment data
 * Automatic inline flow heating of the dialysis solution to body temperature
   directly during the inflow phase -  no need to preheat the solution bag
   upfront/in advance of the treatment
 * Automatic draining feature – the solution bags and the line set are drained
   automatically, no manual handling needed

Simple installation
 * Plug & use – no transformer needed due to double installation

Training support
 * Guiding animations directly on the device
 * Large touch screen

Environmentally friendly
 * sleep•safe harmony system daily disposables are made of PVC-free and
   plasticizer-free materials such as Biofine (Except APD drainage options)




OUR PRODUCTS - KEY FEATURES OF SILENCIA

SILENCIA is delivering individual APD therapy in a reliable and convenient way,
providing the following benefits :

 * Improved sleep quality due to silent operation and soft alarms4,5
 * Simple design enables easy setup and short training time6
 * APD individualization as supported by the latest ISPD guidelines7
 * Developed for home use even with limited space
 * High patient satisfaction with the handling of the SILENCIA cycler
 * Increased treatment flexibility with FlexPoint technology3 


ADAPTED APD (AAPD) IS ONE WAY TO PERSONALIZE TREATMENTS

sleep•safe harmony and SILENCIA offer multiple options to individualize
prescriptions according to patients' needs. Using our APD cyclers, the
prescription can be individualized on several levels:

 * Infusion volume
 * Dwell time
 * Glucose profile
 * Calcium profile
 * FlexPoint


Different PD solutions per cycle within the same treatment can be used with
sleep•safe harmony.


BECAUSE EVERY PATIENT IS DIFFERENT: AAPD – FISCHBACH ET AL.2 SUGGESTS POTENTIAL
BETTER RESULTS USING THE SAME TIME AND RESOURCES2

Your patients have a chronic disease in common, but differ in many ways: age,
height, weight, stage of illness, residual kidney function etc. These
differences have a decision impact on the PD treatment required. 
Patients’ needs are different:

Age

Age is an important factor influencing the choice of dialysis modality. Patients
with good dexterity and motivation are good candidates for PD. With increasing
age, the associated comorbidities of dialysis patients might deteriorate and
with it their frailty.

Weight

Management of weight is an important success factor in PD patients. Changes in
weight due to lifestyle, calorie intake, disease and hydration status need
constant monitoring and adaptation of PD therapy.

D/P creatinine

Dialysate to plasma ratio is a common measure used to evaluate peritoneal
transport characteristic in PD patients. Patients can be into high (fast), high
average and low (slow) transporters based depending upon the status of their
peritoneal membrane.  Peritoneal membrane transport characteristics change with
time on PD. Therefore, regular monitoring of D/P creatinine and subsequent
adjustment of PD prescriptions is recommended.

Transporter type

Patients are classified into high (fast), high average and low (slow)
transporters based on the function of their peritoneal membrane. With time and
increasing duration of stay on PD, patients tend to become fast transporters. PD
prescriptions need to be adapted according to patients' transport status for an
optimal patient outcome.

Residual kidney function (RKF)

RKF has an impact on patient survival and quality of life of PD dialysis
patients. Its longer preservation is a major advantage. Thus, interventions to
preserve RKF, like prescription of biocompatible PD fluids, are important.

Ultrafiltration

Due to compromised kidney function, bodies' own capacity to remove excess fluid
also diminishes and patients need dialysis to generate UF. The amount of UF
needed varies depending upon many factors, like lifestyle, disease progression
and other comorbid conditions. An adequate UF is therefore critical for
successful PD.

Kt/V urea

Kt/V urea is urea clearance normalized to total body water. It is an important
parameter to check PD adequacy. A total Kt/V urea of at least 1.7 per week is
recommended for PD patients.8




FISCHBACH STUDY SUPPORTS AAPD2

Fischbach M. et al. conducted a randomized, prospective, cross-over, multicenter
study. Nineteen patients were included in the final analysis.

According to Fischbach et al., aAPD offers better results using the same time
and resources2

 * aAPD is possible without extra fluids or a longer amount of time
 * Efficiently uses existing treatment resources: better ultrafiltration and
   clearance with same, low glucose concentration, fluid volume and treatment
   time compared to conventional APD (cAPD)


ATTAINING ADEQUACY TARGETS

The aAPD approach was proposed by Fischbach M. et al.2 By combining sequences of
short dwells and small fill volumes with long dwells and large fill volumes,
aAPD aims to promote UF and clearance within one PD session. The blood
purification and UF achieved for every gram of glucose absorbed was higher in
aAPD in comparison to cAPD.


THE CHALLENGES OF PD – REACHING ADEQUACY TARGETS

Reaching adequacy targets in PD for both UF and clearance is challenging.
Fischbach et al. propose that shorter dwell times and smaller fill volumes
promote the process of UF, while longer dwell times and large fill volumes
increase solute clearance.2 The proposed strategy may have the potential to
improve the two targets within one PD session.


CAPD

Figure 1: Modified cAPD graphic following Fischbach M. et al.




AAPD

Figure 2: Modified aAPD graphic following Fischbach M. et al.

Adapted APD is possible without extra fluids or a longer amount of time, with
the same glucose concentration.

The study results suggest that, compared with cAPD, targeting UF vs. clearance
separately, by varying dwell times and fill volumes may improve dialysis
adequacy with a reduction in metabolic burden.2


COMPARISON AFTER 45 DAYS1

Figure 3: Figure created based on study data from Fischbach, M. et al.,
comparing mean daily UF and sodium removal after 45 days, showing better UF
(+100 mL/session) and sodium removal (+14 mmol/session) for aAPD



Figure 4: Figure created based on study data from Fischbach, M. et al,. Higher
clearance with aAPD over glucose absorbed


SUMMARY OF POTENTIAL PATIENT BENEFITS AS REPORTED BY FISCHBACH ET AL2

Patient benefits

 * Improves ultrafiltration
 * Better sodium removal
 * Lower blood pressure
 * Promotes clearance: urea, creatinine, phosphate
 * Reduced metabolic load
    

Clinical value

 * Improved use of existing treatment resources: better ultrafiltration and
   clearance with same, low glucose concentration, fluid volume and treatment
   time compared to cAPD


APD MONITORING AND SUPPORT

Smart digital tools offer convenience for patients and caregivers in the comfort
of the patients’ homes.

3

TREATMENT

SUPPORT

 * A simple ordering process in combination with personal phone support ensures
   that patients can order materials anytime and anywhere
 * The delivery service ensures that PD solutions and disposables are delivered
   straight to your patient’s doorstep
 * The PD travel service enables patients to continue travelling as the required
   goods are directly sent to the patient’s holiday destination*

MONITOR

 * Streamlined PD therapy management through easy accessibility to therapy
   information via our PatientOnLine tool

* The service is not available in all countries. The availability of the service
and products must be clarified before planning or booking a vacation.


DISCLAIMER

Not all products and services are cleared or available for sale in all EU
countries. Check your country web site for details. 

Related content


PERITONEAL DIALYSIS – AN OVERVIEW

Fresenius Medical Care offers holistic solutions for CAPD and APD patients,
which includes supporting patients in preparing for PD with training solutions
and the set up.




CAPD

The stay•safe system helps patients with daily self-care CAPD treatment in a
simple and convenient way.


References

1 Roumeliotis A et al. Int Urol Nephrol 2021; 53(6):1149-1160

2 Fischbach M et al. Peritoneal Dial Int 2011; 31(4):450-458

3 Punzalan S et al. Journ of Kidn Care 2017; 2(5):262-267

4 Morales R et al. 2021 ISPD Congress, PO-40 (abstract, article submitted)

5 Unpublished data on file at Fresenius Medical Care DeutschlandGmbH; with
operation noise of LAeq 12-14 dB classification as “silently operating”
according to Berglund, Birgitta, Lindvall, Thomas, Schwela, Dietrich H & World
Health Organization. Occupational and Environmental Health Team. (1999).
Guidelines for community noise. World Health Organization, page 10, available as
download under https://apps.who.int/iris/handle/10665/66217; site was accessed
the last time 31/07/2023; 16:35 CET

6 Unpublished data on file at Fresenius Medical Care Deutschland GmbH (short
training times)

7 Brown EA et al. Perit Dial Int. 2020;40(3):244-253.

8 Tzamaloukas AH et al. Semin Dial 2008; 21(3):250-257

To top:
Share:
 * 
 * 
 * 
 * 
 * 

News

06/12/2024

Fresenius Medical Care takes next important step towards goal to reduce CO2
emissions in its operations

05/28/2024

Liberty Dialysis Opens First Patient Training Center for Home Hemodialysis in
Windward O‘ahu

05/23/2024

Moody’s and S&P change Fresenius Medical Care’s rating outlook to stable

See all news

Media center

STORY

The Far-Reaching Impacts of the CONVINCE Study

STORY

Dialysis Nurse Turned Patient Brings a Positive Attitude to Treatments

COMPANY FEATURE

Dr. Benjamin Hippen on the Improving Organ Transplant Access Rule

Go to media center

Quick links

INVESTORS

Financial calendar


HEALTHCARE PROFESSIONALS

Training and education
Events and congresses
Educational grants


LEGAL AND REGULATORY

Medical device regulation (MDR)
SVHC information (REACH)
Trade governance
Product information


Contact
Country websites Global website Australia Austria Brazil Chile China Colombia
Czech Republic Denmark Ecuador Finland France Germany Hong Kong Hungary India
Indonesia Italy Japan Kazakhstan Korea Malaysia Mexico Middle East Morocco
Pakistan Philippines Peru Poland Portugal Romania Russia Singapore South Korea
Spain Sweden Switzerland Taiwan Thai Türkiye Ukraine United Kingdom United
States Vietnam

All contact information


Social Media
 * Facebook
 * X
 * Youtube
 * LinkedIn

Select language
EN DE
 * Privacy policy
 * Cookie settings
 * Imprint

© Fresenius Medical Care AG 2024
Fresenius Medical Care uses cookies on this website to enhance the user
experience, provide the best possible service, analyze site usage and for
marketing purposes. By clicking “Accept All”, you agree to the storing of store
such cookies on your device. By clicking “Reject all”, only strictly necessary
cookies will be used. For more information please see our privacy policy.
Cookies Settings Reject All Accept All



PRIVACY PREFERENCE CENTER

When you visit any web site, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalised web experience. Because we respect your right to
privacy, you can choose not to allow some types of cookies. Click on the
different category headings to find out more and change our default settings.
However, blocking some types of cookies may impact your experience of the site
and the services we are able to offer. To see a list of cookies used on this
website, see the Cookies Declaration link on the privacy page.
More Information
Allow All


MANAGE CONSENT PREFERENCES

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for the website to function or deliver a requested
service. They are usually set in response to actions made by you, such as
allowing access to content after logging in or saving the progress on a form you
are filling out. They cannot be switched off by us in our systems. You can still
set your browser to block or alert you about these cookies, but some parts of
the site will not then work.

PERFORMANCE COOKIES

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated.

Back Button


COOKIE LIST



Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

Confirm My Choices